vs

Side-by-side financial comparison of HUTCHMED (China) Ltd (HCM) and POTLATCHDELTIC CORP (PCH). Click either name above to swap in a different company.

POTLATCHDELTIC CORP is the larger business by last-quarter revenue ($314.2M vs $270.8M, roughly 1.2× HUTCHMED (China) Ltd). POTLATCHDELTIC CORP runs the higher net margin — 8.2% vs 0.7%, a 7.5% gap on every dollar of revenue. On growth, POTLATCHDELTIC CORP posted the faster year-over-year revenue change (23.1% vs -16.5%). POTLATCHDELTIC CORP produced more free cash flow last quarter ($50.1M vs $3.4M).

HUTCHMED (China) Ltd is a biopharmaceutical firm focused on discovering, developing and commercializing targeted and immunotherapies for oncology and immunological diseases. It operates across China and global markets, with multiple marketed oncology drugs and a robust pipeline of late-stage clinical candidates addressing unmet patient needs.

PotlatchDeltic Corporation is an American diversified forest products company based in Spokane, Washington.

HCM vs PCH — Head-to-Head

Bigger by revenue
PCH
PCH
1.2× larger
PCH
$314.2M
$270.8M
HCM
Growing faster (revenue YoY)
PCH
PCH
+39.7% gap
PCH
23.1%
-16.5%
HCM
Higher net margin
PCH
PCH
7.5% more per $
PCH
8.2%
0.7%
HCM
More free cash flow
PCH
PCH
$46.8M more FCF
PCH
$50.1M
$3.4M
HCM

Income Statement — Q4 FY2025 vs Q3 FY2025

Metric
HCM
HCM
PCH
PCH
Revenue
$270.8M
$314.2M
Net Profit
$2.0M
$25.9M
Gross Margin
37.7%
18.2%
Operating Margin
-13.2%
11.2%
Net Margin
0.7%
8.2%
Revenue YoY
-16.5%
23.1%
Net Profit YoY
-83.6%
682.5%
EPS (diluted)
$0.00
$0.33

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HCM
HCM
PCH
PCH
Q4 25
$270.8M
Q3 25
$314.2M
Q2 25
$277.7M
$275.0M
Q1 25
$324.5M
$268.3M
Q4 24
$258.1M
Q3 24
$255.1M
Q2 24
$305.7M
$320.7M
Q1 24
$228.1M
Net Profit
HCM
HCM
PCH
PCH
Q4 25
$2.0M
Q3 25
$25.9M
Q2 25
$455.0M
$7.4M
Q1 25
$11.9M
$25.8M
Q4 24
$5.2M
Q3 24
$3.3M
Q2 24
$25.8M
$13.7M
Q1 24
$-305.0K
Gross Margin
HCM
HCM
PCH
PCH
Q4 25
37.7%
Q3 25
18.2%
Q2 25
0.1%
13.0%
Q1 25
48.0%
17.8%
Q4 24
13.4%
Q3 24
10.8%
Q2 24
41.1%
11.9%
Q1 24
7.0%
Operating Margin
HCM
HCM
PCH
PCH
Q4 25
-13.2%
Q3 25
11.2%
Q2 25
-1.3%
5.0%
Q1 25
-5.0%
10.3%
Q4 24
5.2%
Q3 24
2.8%
Q2 24
-9.0%
5.4%
Q1 24
-2.1%
Net Margin
HCM
HCM
PCH
PCH
Q4 25
0.7%
Q3 25
8.2%
Q2 25
163.8%
2.7%
Q1 25
3.7%
9.6%
Q4 24
2.0%
Q3 24
1.3%
Q2 24
8.4%
4.3%
Q1 24
-0.1%
EPS (diluted)
HCM
HCM
PCH
PCH
Q4 25
$0.00
Q3 25
$0.33
Q2 25
$0.52
$0.09
Q1 25
$0.01
$0.33
Q4 24
$0.07
Q3 24
$0.04
Q2 24
$0.03
$0.17
Q1 24
$0.00

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HCM
HCM
PCH
PCH
Cash + ST InvestmentsLiquidity on hand
$1.4B
$88.8M
Total DebtLower is stronger
$93.2M
Stockholders' EquityBook value
$1.2B
$1.9B
Total Assets
$1.8B
$3.2B
Debt / EquityLower = less leverage
0.08×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HCM
HCM
PCH
PCH
Q4 25
$1.4B
Q3 25
$88.8M
Q2 25
$1.4B
$95.3M
Q1 25
$836.1M
$147.5M
Q4 24
$151.6M
Q3 24
$161.1M
Q2 24
$802.5M
$199.7M
Q1 24
$180.2M
Total Debt
HCM
HCM
PCH
PCH
Q4 25
$93.2M
Q3 25
Q2 25
$93.4M
Q1 25
$82.8M
Q4 24
$1.0B
Q3 24
Q2 24
$82.1M
Q1 24
Stockholders' Equity
HCM
HCM
PCH
PCH
Q4 25
$1.2B
Q3 25
$1.9B
Q2 25
$1.2B
$1.9B
Q1 25
$759.9M
$2.0B
Q4 24
$2.0B
Q3 24
$2.1B
Q2 24
$740.1M
$2.1B
Q1 24
$2.2B
Total Assets
HCM
HCM
PCH
PCH
Q4 25
$1.8B
Q3 25
$3.2B
Q2 25
$1.8B
$3.2B
Q1 25
$1.3B
$3.3B
Q4 24
$3.3B
Q3 24
$3.3B
Q2 24
$1.3B
$3.4B
Q1 24
$3.4B
Debt / Equity
HCM
HCM
PCH
PCH
Q4 25
0.08×
Q3 25
Q2 25
0.08×
Q1 25
0.11×
Q4 24
0.51×
Q3 24
Q2 24
0.11×
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HCM
HCM
PCH
PCH
Operating Cash FlowLast quarter
$8.2M
$65.7M
Free Cash FlowOCF − Capex
$3.4M
$50.1M
FCF MarginFCF / Revenue
1.2%
15.9%
Capex IntensityCapex / Revenue
1.8%
4.9%
Cash ConversionOCF / Net Profit
4.21×
2.54×
TTM Free Cash FlowTrailing 4 quarters
$-96.2M
$132.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HCM
HCM
PCH
PCH
Q4 25
$8.2M
Q3 25
$65.7M
Q2 25
$-72.9M
$41.0M
Q1 25
$40.3M
$49.1M
Q4 24
$45.4M
Q3 24
$26.5M
Q2 24
$-39.8M
$100.6M
Q1 24
$16.0M
Free Cash Flow
HCM
HCM
PCH
PCH
Q4 25
$3.4M
Q3 25
$50.1M
Q2 25
$-82.2M
$30.6M
Q1 25
$32.5M
$26.3M
Q4 24
$25.4M
Q3 24
$-8.2M
Q2 24
$-49.9M
$72.4M
Q1 24
$2.0M
FCF Margin
HCM
HCM
PCH
PCH
Q4 25
1.2%
Q3 25
15.9%
Q2 25
-29.6%
11.1%
Q1 25
10.0%
9.8%
Q4 24
9.9%
Q3 24
-3.2%
Q2 24
-16.3%
22.6%
Q1 24
0.9%
Capex Intensity
HCM
HCM
PCH
PCH
Q4 25
1.8%
Q3 25
4.9%
Q2 25
3.3%
3.8%
Q1 25
2.4%
8.5%
Q4 24
7.7%
Q3 24
13.6%
Q2 24
3.3%
8.8%
Q1 24
6.1%
Cash Conversion
HCM
HCM
PCH
PCH
Q4 25
4.21×
Q3 25
2.54×
Q2 25
-0.16×
5.58×
Q1 25
3.38×
1.90×
Q4 24
8.74×
Q3 24
7.99×
Q2 24
-1.54×
7.35×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

HCM
HCM

Segment breakdown not available.

PCH
PCH

Lumber$131.8M42%
Timberlands$52.5M17%
Rural Real Estate$51.3M16%
Residuals And Panels$34.0M11%
Pulpwood$16.7M5%
Development Real Estate$14.6M5%
Other$8.1M3%
Other Products$5.2M2%

Related Comparisons